California biotech company Exelixis is opening a temporary base in King of Prussia in June as it explores sites in the King of Prussia, Conshohocken, and Plymouth Meeting areas for a future built-to suit expansion, writes Natalie Kostelni for the Philadelphia Business Journal.
The company’s temporary 23,000-square-foot space at 640 Freedom Business Center Drive will accommodate an initial 135 to 140 employees. They are anticipating it will use the location for the next two years.
“Ultimately, it will really be a major campus for Exelixis,” said Vicki Goodman, Exelixis executive vice president and chief medical officer.
The company focuses on cancer treatments. Its decision to establish a significant presence in the Philadelphia region – referred to as Exelixis East – is being driven by several factors, including the need for talent.
“We see the Philadelphia area as a great base of talent with the right education and background across Southeastern Pennsylvania, adjacent areas of New Jersey and Central New Jersey, as well as Wilmington,” said Goodman. “We see this as an ideal place to set up a center of operations.”
Ultimately, the company plans to employ several hundred people in the area.
Read more about Exelixis moving to King of Prussia in the Philadelphia Business Journal.